Bausch & Lomb Incorporated [clinicaltrials_resource:01e1f27a9c910d817c4d37692af53ce0]
Kenneth Harper [clinicaltrials_resource:06e5354e7c6d2e2b09bfd73ca3f31458]Joanne Egamino, PhD [clinicaltrials_resource:0885eadbe4b050c11e5f2e95b7784ca8]Gerard Carains, MCOptom, PhD [clinicaltrials_resource:08b2866fd4a6c961043182fc93606113]Helmut Allmeier, PhD [clinicaltrials_resource:0e58c30ea78b7e6402ad2145e9040f75]Rabia Ozden, OD [clinicaltrials_resource:10c6d6a9b546f3bb1acd428540e323de]Laura Trusso [clinicaltrials_resource:15d9da6d88fe4063a5f602f20118ff2e]Beverly Barna [clinicaltrials_resource:1daeee46773ad66b4eeca3fc4dcc0bb4]Alyson J Berliner, MD/PhD [clinicaltrials_resource:2055b4ca1fbed2f318e8ae65432f3382]Timothy L Comstock, DO [clinicaltrials_resource:2222b14e3b58c5c8594f1176266a24e8]Bev Barna, CCRA [clinicaltrials_resource:33a7bcefa581b458dc15ffdd81aea2c7]Beverly J Barna [clinicaltrials_resource:33f53299e90f84746db2214f0abfda60]Tuyen Ong, MD [clinicaltrials_resource:34cd2634e597c1e937d415448ce1594b]Jon I Williams, PhD [clinicaltrials_resource:367d2a4c76a4423845eceee41bd72d53]Anne Williart, MD [clinicaltrials_resource:37657fdaacb4cf62a169d81676b1938c]Catherine Allaire, MD [clinicaltrials_resource:398e34a260fc8e1b2f052d453ac3bfa7]Jeffery Schafer, OD, MS [clinicaltrials_resource:398ff1612aac8b89894090a60ea83ff3]Rabia Ozden, MD [clinicaltrials_resource:41f949218467bc5038f59eb16bddc21f]Gerard Cairns, MCOptom, PhD [clinicaltrials_resource:4c065c350cd64b7e832aee00ca35ae97]Laura Trusso, MS [clinicaltrials_resource:51d5f3a40bb086d61b973fcc980c7332]Jason L. Vittitow, PhD [clinicaltrials_resource:559662474132232b316b83e1156721f1]Robert Steffen, OD, MS [clinicaltrials_resource:60fdab866d0b647b07f032ea5f3bf2f3]Bev Barna [clinicaltrials_resource:6eab41095bc71ff3ec8c8829a36e1203]Gerard Cairns, PhD, MCOptom [clinicaltrials_resource:7407b87b1c32565ec00f0b5e142165b3]Gabriele Brenger [clinicaltrials_resource:7b5882608b0dce32c1869567a166f4c7]Jon Williams, Ph.D. [clinicaltrials_resource:83f6835bae78af0e1f565c806a1de125]Beverly Barna, CCRA [clinicaltrials_resource:88e3821d07d41b03e6898bef87d1708a]Gerard Cairns, PhD,MCOptom [clinicaltrials_resource:8e5e50728e286d17b672abba8e954341]Omid Khodai, OD, RAC [clinicaltrials_resource:8fd0b4f3cc4d66b2e06d7a53903dab89]Mohinder Merchea, OD, PhD [clinicaltrials_resource:902d16dd48fceb4fe18e6da76517590f]Stephanie Su, OD [clinicaltrials_resource:9041e939195aed3cdf6797f14db08ecb]Esther Chu [clinicaltrials_resource:92c2c9efafb404e186e582717719f0bb]Timothy Comstock, OD [clinicaltrials_resource:9753e2d2c545d28e1ecd24990f7f666f]Quintus Ngumah, OD, PhD [clinicaltrials_resource:9a764d6b93d396cb47467a925a78bd94]Jason Vittitow [clinicaltrials_resource:b562862cfc7a43fc012096370a79773f]Tara Vaz, OD [clinicaltrials_resource:cd7db6630a022fc4abe3fbcbedde0060]Michele Lagana [clinicaltrials_resource:d85b8b7a11a3aee0abdb3f250a4ae3d7]Tes Ignacio, MD [clinicaltrials_resource:e05b70aa304303f65a383211c34637f9]Quintus Ngumah, OD,PhD [clinicaltrials_resource:e3ed1e8243dacb553d5edc6aa75e3a02]Timothy L Comstock, OD [clinicaltrials_resource:e62523d3952f495e09e10082701bd443]Michael R Paterno, OD [clinicaltrials_resource:ee1f29ed85b86dae838b8e7a6f9c5512]
affiliation [clinicaltrials_vocabulary:affiliation]
Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma [clinicaltrials:NCT00441883]Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Subjects With Ocular Redness. [clinicaltrials:NCT01959230]Safety of Brimonidine Tartrate Ophthalmic Solution in a Population of Pediatric, Adult, and Geriatric Subjects. [clinicaltrials:NCT01959243]Pharmacokinetics and Safety of Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025%. [clinicaltrials:NCT02039765]Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Subjects With Tinea Pedis and Tinea Cruris [clinicaltrials:NCT02394340]Post Approval Study to Evaluate the Trulign™ Toric Posterior Chamber IOL [clinicaltrials:NCT02394379]
collaborator [clinicaltrials_vocabulary:collaborator]
Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase) [clinicaltrials:NCT00198419]Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery [clinicaltrials:NCT00198445]Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase) [clinicaltrials:NCT00198458]Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment [clinicaltrials:NCT00198471]Evaluation of Vitrase as a Spreading Agent [clinicaltrials:NCT00198484]Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage [clinicaltrials:NCT00198497]Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage [clinicaltrials:NCT00198510]A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte [clinicaltrials:NCT00198523]Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome [clinicaltrials:NCT00198536]Evaluation of Vitrase as an Adjuvant to Increase Absorption and Dispersion of Other Injected Anesthetics [clinicaltrials:NCT00198549]Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery [clinicaltrials:NCT00333918]A Clinical Evaluation of the Next Generation Diagnostic Instrument (NGDI) [clinicaltrials:NCT00347594]A Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment (PVD) [clinicaltrials:NCT00347646]clinicaltrials:NCT00347932A Study to Evaluate the Safety and Effectiveness of the 217z Laser With Zyoptix for Lasik [clinicaltrials:NCT00347997]A Study to Evaluate the Safety and Effectiveness of the Technols 217z Zyoptix System for Hyperopia [clinicaltrials:NCT00348205]clinicaltrials:NCT00348348Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment [clinicaltrials:NCT00348439]A Study to Investigate the Safety and Effectiveness of Aspheric Laser Refractive Surgery Treatments for Myopia [clinicaltrials:NCT00365677]Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome [clinicaltrials:NCT00370747]A Study Of The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis [clinicaltrials:NCT00375596]Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implants [clinicaltrials:NCT00407082]Systemic Pharmacokinetics of BOL-303224-A [clinicaltrials:NCT00407589]clinicaltrials:NCT00420628Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis [clinicaltrials:NCT00423007]clinicaltrials:NCT00424398Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma [clinicaltrials:NCT00441883]Zylet vs TobraDex in Blepharokeratoconjunctivitis [clinicaltrials:NCT00447577]Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant [clinicaltrials:NCT00456482]Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy [clinicaltrials:NCT00468871]Efficacy of Fluocinolone Acetonide Intravitreal Implant in Diabetic Macular Edema [clinicaltrials:NCT00502541]Ocular Tolerance and Intraocular Pressure (IOP) Effects of Zylet Versus Tobradex [clinicaltrials:NCT00532961]Loteprednol Etabonate Opthalmic Suspension for the Treatment of Dry Eye [clinicaltrials:NCT00560638]Safety and Efficacy of Intravitreal Fluocinolone Acetonide Implants in Patients With Diabetic Macular Edema [clinicaltrials:NCT00576459]Efficacy and Safety of Bromfenac Ophthalmic Solution [clinicaltrials:NCT00585975]Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers [clinicaltrials:NCT00586625]clinicaltrials:NCT00586664A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension. [clinicaltrials:NCT00595101]clinicaltrials:NCT00622908Comparative Performance of a Bausch & Lomb Multipurpose Solution and Alcon OptiFree Replenish Multipurpose Solution [clinicaltrials:NCT00636194]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
William Reindel, Bausch & Lomb Incorporated [clinicaltrials_resource:2d16d0779639d185c87a3edfcfbc01cb]Mohinder Merchea, OD, PhD, MBA, Bausch & Lomb Incorporated [clinicaltrials_resource:ab61d0e8ba80d8fd04a7afd1392c6b51]Tuyen Ong, MD, Bausch & Lomb Incorporated [clinicaltrials_resource:cd94379208c4bd07bf3a0e3ca8599a53]
organization [clinicaltrials_vocabulary:organization]
Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase) [clinicaltrials:NCT00198419]Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery [clinicaltrials:NCT00198445]Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase) [clinicaltrials:NCT00198458]Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment [clinicaltrials:NCT00198471]Evaluation of Vitrase as a Spreading Agent [clinicaltrials:NCT00198484]Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage [clinicaltrials:NCT00198497]Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage [clinicaltrials:NCT00198510]A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte [clinicaltrials:NCT00198523]Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome [clinicaltrials:NCT00198536]Evaluation of Vitrase as an Adjuvant to Increase Absorption and Dispersion of Other Injected Anesthetics [clinicaltrials:NCT00198549]Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery [clinicaltrials:NCT00333918]A Clinical Evaluation of the Next Generation Diagnostic Instrument (NGDI) [clinicaltrials:NCT00347594]A Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment (PVD) [clinicaltrials:NCT00347646]clinicaltrials:NCT00347932A Study to Evaluate the Safety and Effectiveness of the 217z Laser With Zyoptix for Lasik [clinicaltrials:NCT00347997]A Study to Evaluate the Safety and Effectiveness of the Technols 217z Zyoptix System for Hyperopia [clinicaltrials:NCT00348205]clinicaltrials:NCT00348348Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment [clinicaltrials:NCT00348439]A Study to Investigate the Safety and Effectiveness of Aspheric Laser Refractive Surgery Treatments for Myopia [clinicaltrials:NCT00365677]Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome [clinicaltrials:NCT00370747]A Study Of The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis [clinicaltrials:NCT00375596]Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implants [clinicaltrials:NCT00407082]Systemic Pharmacokinetics of BOL-303224-A [clinicaltrials:NCT00407589]clinicaltrials:NCT00420628Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis [clinicaltrials:NCT00423007]clinicaltrials:NCT00424398Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma [clinicaltrials:NCT00441883]Zylet vs TobraDex in Blepharokeratoconjunctivitis [clinicaltrials:NCT00447577]Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant [clinicaltrials:NCT00456482]Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy [clinicaltrials:NCT00468871]Efficacy of Fluocinolone Acetonide Intravitreal Implant in Diabetic Macular Edema [clinicaltrials:NCT00502541]Ocular Tolerance and Intraocular Pressure (IOP) Effects of Zylet Versus Tobradex [clinicaltrials:NCT00532961]Loteprednol Etabonate Opthalmic Suspension for the Treatment of Dry Eye [clinicaltrials:NCT00560638]Safety and Efficacy of Intravitreal Fluocinolone Acetonide Implants in Patients With Diabetic Macular Edema [clinicaltrials:NCT00576459]Efficacy and Safety of Bromfenac Ophthalmic Solution [clinicaltrials:NCT00585975]Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers [clinicaltrials:NCT00586625]clinicaltrials:NCT00586664A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension. [clinicaltrials:NCT00595101]clinicaltrials:NCT00622908Comparative Performance of a Bausch & Lomb Multipurpose Solution and Alcon OptiFree Replenish Multipurpose Solution [clinicaltrials:NCT00636194]
source [clinicaltrials_vocabulary:source]
Bausch & Lomb Incorporated [clinicaltrials_resource:01e1f27a9c910d817c4d37692af53ce0]
Bio2RDF identifier
01e1f27a9c910d817c4d37692af53ce0
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:01e1f27a9c910d817c4d37692af53ce0
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:01e1f27a9c910d817c4d37692af53ce0
title
Bausch & Lomb Incorporated
@en
type
label
Bausch & Lomb Incorporated [clinicaltrials_resource:01e1f27a9c910d817c4d37692af53ce0]
@en